Work

Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.3143

Authors: Stephanie Gu, Stephen W Dusza, Ira J. Dunkel, Alexander E. Drilon, Mario E. Lacouture, Alina Markova

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379282822

Cites:

Cited by: 1

Related to: 10